Phase 3 Prospective, Randomized, Controlled and Double-blinded Second Trial on Pain Relief by Continuous Intra-peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia, During Gynecological Laparoscopic Surgery (PSDR)

NCT00927979 Phase 3 COMPLETED

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.

Details

Lead sponsor	Carmel Medical Center
Phase	Phase 3
Status	COMPLETED
Enrolment	40
Start date	2009-06
Completion	2010-10

Conditions

• Gynecological Laparoscopy

Interventions

• 10 mLRopivacaine 1%
• Water for injection
• 10 mL Ropivacaine 1%

Primary outcomes

• Visual Analog Score (VAS) — 24 hours